Susan Li, PhD

Peptide Chief Scientist at Asymchem

Speaker

Susan Li holds a PhD in Polymer Chemistry and Physics from Nankai University in China. She completed a postdoctoral fellowship at the University of Texas Southwestern Medical Center (UTSW) in the United States. Before joining Asymchem, she previously worked at PolyPeptide Group where she focused on CMC development for peptide APIs. She also served as a Senior Scientist in the Department of Macromolecular Life Sciences and Cancer Biology at the Stanford Research Institute (SRI), leading efforts to establish a peptide-targeted drug platform for cancer treatment and diagnosis. In 2019, Susan became the Director of Peptide R&D at Sinopep Biopharmaceutical Co., Ltd. in China, where she led the development of peptide APIs, including Semaglutide and Desmopressin. Under her leadership, the DMFs for these compounds were successfully completed and found to meet FDA standards. Currently, Susan works as the Peptide Chief Scientist at Asymchem Group, overseeing peptide CMC development and manufacturing.